International Marijuana Business News

Germany reveals wholesale medical cannabis price at 2.3 euros per gram, signaling no windfall for suppliers

The German federal government will buy at least 650 kilograms (1,433 pounds) of medical cannabis flower from domestic producers for approximately 1.5 million euros ($1.66 million) per quarter, which sets the average wholesale price at 2.3 euros per gram. The wholesale price implies that the high margins medical marijuana companies once enjoyed in that market could […]

Read More

Recreational cannabis sales in Eastern Canada punished by lack of retail expansion

Adult-use cannabis sales fell sharply in September in every Eastern Canadian market except Quebec, a reflection of the industry’s inability to open new stores to meet consumer demand in those provinces. Overall sales of recreational marijuana in Ontario, Quebec, Newfoundland, Nova Scotia, Prince Edward Island and New Brunswick declined 5.5% to 71 million Canadian dollars […]

Read More

Israel unveils six-month transitional guidelines for medical cannabis exports

Israel’s Medical Cannabis Agency has unveiled transitional guidelines that would approve medical cannabis exports on a case-by-case basis provided local supplies are sufficient to meet patient demand, giving licensed companies a new market to sell their product. The new guidelines, which will be in place for at least six months, were laid out by the […]

Read More

Report: Ontario to allow private sector wholesale of cannabis

Ontario’s government plans to loosen its grip on adult-use cannabis distribution and allow private-sector participation. Currently, recreational marijuana wholesaling in the province is under the sole domain of the government-owned Ontario Cannabis Store (OCS). According to an email obtained by the Financial Post, “The OCS is moving ahead with expanding its privately-operated third-party centralized distribution […]

Read More

Tips for entering Europe’s medical cannabis market: Q&A with Christian Carlsen of Danish pharma firm NNE

Could medical cannabis be a growth engine for the pharmaceutical industry? A subsidiary of Danish pharmaceutical giant Novo Nordisk is betting the answer is yes. NNE A/S, a 1,000-person strong pharmaceutical engineering and advisory unit of Novo Nordisk A/S , has been counselling medical cannabis companies on establishing pharmaceutical-grade facilities in Europe and Asia. NNE’s cannabis […]

Read More

England’s health insurance has covered only 18 ‘unlicensed’ cannabis prescriptions

Since a new law took effect a year ago, England’s National Health Service (NHS) has reimbursed patients on only 18 occasions for “unlicensed” cannabis-based products that have not undergone clinical trials, according to government data. In the case of private prescriptions – which are paid out of pocket by patients – the number of prescriptions reached 104. The data […]

Read More

Health Canada OK with Hexo’s proactive fix on unlicensed cannabis cultivation

Actions undertaken by Quebec cannabis producer Hexo Corp. to proactively rectify unauthorized cultivation were deemed “acceptable” by Canada’s federal health department. The company disclosed late Friday that unlicensed cultivation took place inside part of a facility the company acquired last spring. Hexo’s 260 million Canadian dollar ($180 million) purchase of Newstrike Brands, owner of Up […]

Read More

BC offers CA$676,000 to help cannabis entrepreneurs join legal market

A small portion of an employment fund worth 15 million Canadian dollars ($11 million) is being set aside by British Columbia’s government to help gray-market cannabis entrepreneurs in one region of the province gain a foothold in the legal economy. The funding for the program, amounting to CA$676,000, is being directed to the Cannabis Business Transition Initiative, which […]

Read More